Vimarsana
Biggest News Aggregation in the World

Ashwin Vasava News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ashwin Vasava. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ashwin Vasava Today - Breaking & Trending Today

Scrub Typhus: Uncommon Scrub Typhus Disease Reported from Narmada Surat | Surat News - Vimarsana News

Scrub Typhus: Uncommon Scrub Typhus Disease Reported from Narmada Surat | Surat News

Read about the case of a deadly and uncommon disease called scrub typhus reported from Dediyapada of Narmada district. Learn about the symptoms, treatment, and recovery of the patient.

Surat: 'National Doctor's Day' celebrated at Civil Hospital - Vimarsana News

Surat: 'National Doctor's Day' celebrated at Civil Hospital

'National Doctor's Day' was celebrated with enthusiasm by 'The Trained Nurses Association of India-Surat' at Surat Civil Hospital's Kidney Building. | BLiTZ

More than 50% mucormycosis patients recovered without steroids: Guj govt - Vimarsana News

More than 50% mucormycosis patients recovered without steroids: Guj govt

More than 50% mucormycosis patients recovered without steroids: Guj govt ​ By IANS | ​ 0 Views China tightens vaccination certificate check for children. Image Source: IANS News Gandhinagar, May 26 : The Gujarat government on Wednesday constituted a task force to bring uniformity in the treatment and protocols for the notified epidemic of mucormycosis in Gujarat. Also the health department released a study which said that more than 50 percent of mucormycosis patients recovered without the need for steroids to fight the fungal infection. Following the central government's advisory, the G...

More than 50% mucormycosis patients recovered without steroids: Gujarat government - Vimarsana News

More than 50% mucormycosis patients recovered without steroids: Gujarat government

It was also observed that 59 percent patients consisted of diabetes patients, 27.1 percent patients were immuno compromised and 15.2 percent were having co-morbidity.